Načítá se...
Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level. We have synthesized 25 tricyclic 2-phenoxypyrido[3...
Uloženo v:
| Vydáno v: | BMC Chem |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661812/ https://ncbi.nlm.nih.gov/pubmed/31384800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-019-0560-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|